{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:35:40Z","timestamp":1787502940870,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["AZV 16-31966A"],"award-info":[{"award-number":["AZV 16-31966A"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["DRO 00209805"],"award-info":[{"award-number":["DRO 00209805"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["LM2015089"],"award-info":[{"award-number":["LM2015089"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["LO1413"],"award-info":[{"award-number":["LO1413"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.intimp.2019.105728","type":"journal-article","created":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T17:33:33Z","timestamp":1562434413000},"page":"105728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Type II hypersensitivity reactions after oxaliplatin rechallenge can be life threatening"],"prefix":"10.1016","volume":"74","author":[{"given":"Jiri","family":"Vyskocil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stepan","family":"Tucek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Fedorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Nevrlka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Zdrazilova-Dubska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2019.105728_bb0005","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/207084","article-title":"Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review","volume":"2010","author":"Makrilia","year":"2010","journal-title":"Metal-Based Drugs"},{"issue":"4","key":"10.1016\/j.intimp.2019.105728_bb0010","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/ijgc-00009577-200807000-00003","article-title":"Analysis of the pattern of hypersensitivity reactions in patients receiving carboplatin retreatment for recurrent ovarian cancer","volume":"18","author":"Gadducci","year":"2008","journal-title":"International journal of gynecological cancer: official journal of the International Gynecological Cancer Society"},{"issue":"3","key":"10.1016\/j.intimp.2019.105728_bb0015","first-page":"213","article-title":"Oxaliplatin immune-induced syndrome occurs with cumulative administration and rechallenge: single institution series and systematic review study","volume":"15","author":"Bencardino","year":"2016","journal-title":"Clin. Colorectal Cancer"},{"issue":"10","key":"10.1016\/j.intimp.2019.105728_bb0020","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1093\/annonc\/mdy306","article-title":"Toxicity of oxaliplatin rechallenge in metastatic colorectal cancer","volume":"29","author":"Mauri","year":"2018","journal-title":"Annals of Oncology: official journal of the European Society for Medical Oncology\/ESMO"},{"issue":"5","key":"10.1016\/j.intimp.2019.105728_bb0025","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.jaip.2017.12.026","article-title":"Incidence and risk of oxaliplatin-induced hypersensitivity in patients with asymptomatic prior exposure: a prospective observational study","volume":"6","author":"Sohn","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.intimp.2019.105728_bb0030","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00280-018-3662-0","article-title":"A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity","volume":"82","author":"Chung","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2019.105728_bb0035","first-page":"1617","article-title":"Hypersensitivity reactions to platinum derivatives: findings of new predictive markers","volume":"20","author":"Cetean","year":"2015","journal-title":"Journal of B.U.ON. : official journal of the Balkan Union of Oncology"},{"issue":"6","key":"10.1016\/j.intimp.2019.105728_bb0040","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1177\/1078155218796190","article-title":"Retrospective evaluation of a rechallenge protocol in patients experiencing hypersensitivity reactions with prior chemotherapy in a tertiary hospital","volume":"25","author":"Wu","year":"2019","journal-title":"Journal of oncology pharmacy practice: official publication of the International Society of Oncology Pharmacy Practitioners"},{"issue":"4","key":"10.1016\/j.intimp.2019.105728_bb0045","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1023\/A:1008336108007","article-title":"Immunohemolytic anemia following oxaliplatin administration","volume":"11","author":"Garufi","year":"2000","journal-title":"Annals of Oncology: Official Journal of the European Society for Medical Oncology\/ESMO"},{"issue":"9","key":"10.1016\/j.intimp.2019.105728_bb0050","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/jjco\/hyp070","article-title":"Allergic reactions to oxaliplatin in a single institute in Japan","volume":"39","author":"Ichikawa","year":"2009","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.intimp.2019.105728_bb0055","series-title":"BCCA Inpatient Protocol Summary for Oxaliplatin Desensitization","author":"BC_Cancer","year":"2016"},{"issue":"12","key":"10.1016\/j.intimp.2019.105728_bb0060","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1182\/blood-2010-03-276691","article-title":"Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods","volume":"116","author":"Reese","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.intimp.2019.105728_bb0065","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1537-2995.1992.32392213813.x","article-title":"Fatal immune hemolytic anemia due to cefotetan","volume":"32","author":"Garratty","year":"1992","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.intimp.2019.105728_bb0070","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1537-2995.1991.31291142951.x","article-title":"A fatal case of ceftriaxone (Rocephin)-induced hemolytic anemia associated with intravascular immune hemolysis","volume":"31","author":"Garratty","year":"1991","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.intimp.2019.105728_bb0075","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1053\/j.ajkd.2010.03.025","article-title":"Hemolysis and acute kidney failure","volume":"56","author":"Qian","year":"2010","journal-title":"American journal of kidney diseases: the official journal of the National Kidney Foundation"},{"issue":"12","key":"10.1016\/j.intimp.2019.105728_bb0080","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/nep.13174","article-title":"Serum procalcitonin levels predict acute kidney injury in critically ill patients","volume":"23","author":"Jeeha","year":"2018","journal-title":"Nephrology (Carlton)"},{"issue":"Supplementum 1","key":"10.1016\/j.intimp.2019.105728_bb0085","first-page":"156","article-title":"Lactate dehydrogenase-old tumour marker in the light of current knowledge and preanalytic conditions","volume":"30","author":"Greplova","year":"2017","journal-title":"Klinicka onkologie: casopis Ceske a Slovenske onkologicke spolecnosti"},{"issue":"4","key":"10.1016\/j.intimp.2019.105728_bb0090","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.anai.2018.01.005","article-title":"Anaphylaxis and severe immune hemolytic anemia during the course of desensitization with carboplatin","volume":"120","author":"Perez-Alzate","year":"2018","journal-title":"Annals of Allergy, Asthma & Immunology: official publication of the American College of Allergy, Asthma, & Immunology"},{"issue":"1","key":"10.1016\/j.intimp.2019.105728_bb0095","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00281-011-0280-x","article-title":"Interactions between coagulation and complement--their role in inflammation","volume":"34","author":"Oikonomopoulou","year":"2012","journal-title":"Semin. Immunopathol."},{"issue":"5","key":"10.1016\/j.intimp.2019.105728_bb0100","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jaip.2013.06.002","article-title":"Carboplatin-, oxaliplatin-, and cisplatin-specific IgE: cross-reactivity and value in the diagnosis of carboplatin and oxaliplatin allergy","volume":"1","author":"Caiado","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.intimp.2019.105728_bb0105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11882-015-0515-3","article-title":"Presentation and diagnosis of hypersensitivity to platinum drugs","volume":"15","author":"Caiado","year":"2015","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.intimp.2019.105728_bb0110","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.2147\/OTT.S154220","article-title":"Rechallenge of oxaliplatin-containing regimens in the third- or later-line therapy for patients with heavily treated metastatic colorectal cancer","volume":"11","author":"Yang","year":"2018","journal-title":"OncoTargets and therapy"},{"issue":"5","key":"10.1016\/j.intimp.2019.105728_bb0115","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12032-018-1124-5","article-title":"Oxaliplatin rechallenge in metastatic colorectal cancer patients after prior oxaliplatin treatment","volume":"35","author":"Kim","year":"2018","journal-title":"Med. Oncol."},{"issue":"6","key":"10.1016\/j.intimp.2019.105728_bb0120","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1537-2995.2004.03111.x","article-title":"An immediate hemolytic reaction induced by repeated administration of oxaliplatin","volume":"44","author":"Chen","year":"2004","journal-title":"Transfusion"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919308707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919308707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:14:07Z","timestamp":1761585247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576919308707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":24,"alternative-id":["S1567576919308707"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.105728","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type II hypersensitivity reactions after oxaliplatin rechallenge can be life threatening","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.105728","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105728"}}